GlassScriptPhysician profile
Ravi Desai
NPI 1558742718
$1,205.83
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $287 · 2021: $919.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $171.70 | 2020-2021 | |
| Abbvie INC. | $165.63 | 2021 | |
| Novo Nordisk INC | $158.99 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $149.85 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $101.11 | 2020-2021 | |
| Lilly USA, LLC | $68.89 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.54 | 2021 | |
| Amgen INC. | $55.62 | 2021 | |
| Merck Sharp & Dohme LLC | $39.47 | 2021 | |
| Novartis Pharmaceuticals Corporation | $34.64 | 2021 | |
| Eisai INC. | $26.10 | 2020 | |
| Pfizer INC. | $25.26 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.58 | 2020-2021 | |
| Smith+Nephew, INC. | $16.64 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.90 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $14.93 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.92 | 2021 | |
| Philips North America LLC | $14.91 | 2020 | |
| Sanofi-Aventis U.S. LLC | $14.26 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.28 | 2021 | |
| Althera Pharmaceuticals LLC | $12.37 | 2021 | |
| Upsher-Smith Laboratories LLC | $12.24 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.